PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-64

  1. 34 Posts.
    lightbulb Created with Sketch. 20
    Looking at these threads, interesting to note the recent flurry of seemingly coordinated posts and threads from a number of posters with longstanding negative views on PAR, often non holders, where you have to question the motives for the time invested in the critique.

    Not saying the opposite hasn't occurred in the past. And some of the views and criticisms are entirely appropriate.

    Just an observation and reminder to keep calm.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.